gr2c5v2v | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Kow%2C_Chia_Siang%3B_Hasan%2C_Syed_Shahzad>
?:doi	10.1016/j.therap.2020.12.015
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.therap.2020.12.015>
?:journal	Therapie
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/d8e6239abea20f90227416f966457014f10f78c4.json
?:pmc_json_files	document_parses/pmc_json/PMC7834767.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7834767>
?:pmid	<https://research.tib.eu/covid-19/entity/33423787.0>
?:pmid	33423787.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/d8e6239abea20f90227416f966457014f10f78c4>
?:source	Elsevier; Medline; PMC
?:title	A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-26

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/gr2c5v2v>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/gr2c5v2v>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all